Dr. Godley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E Superior St
Office 3-113
Chicago, IL 60611Phone+1 312-503-0728Fax+1 312-503-0386
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2003
- University of ChicagoResidency, Internal Medicine, 1997 - 1999
- Northwestern University The Feinberg School of MedicineClass of 1997
Certifications & Licensure
- GA State Medical License 2022 - 2026
- IA State Medical License 2021 - 2026
- IL State Medical License 1997 - 2026
- MD State Medical License 2024 - 2026
- TN State Medical License 2024 - 2026
- WY State Medical License 2024 - 2025
- CO State Medical License 2021 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs Start of enrollment: 2013 Jul 01
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 930 citationsDiagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, Charles Craddock, Courtney D DiNardo
Blood. 2022-09-22 - 995 citationsInternational Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo
Blood. 2022-09-15 - 129 citationsRigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled,...Guillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, Maria R. Baer, Mikkael A. Sekeres
The Lancet. Oncology. 2016-04-01
Abstracts/Posters
- Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological MalignancyLucy A. Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid MalignanciesLucy A. Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDSLucy A Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Friday Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Application of Microarray and Large Datasets to Hematology and Bioinformatics61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Inherited Hematopoietic Malignancies60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
- 203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
- Under Certain Conditions, Bacterial Signals Set the Stage for LeukemiaMay 14th, 2018
- ASH Announces Partnership with UNC to Curate Genomic Data for Blood Disease ResearchApril 6th, 2018
- Join now to see all
Grant Support
- The Role Of DNMT3B In The DNA Methylation Of Cancer CellsNational Cancer Institute2008–2012
- Epigenetic And Genetic Dissection Of Drug ResponseNational Human Genome Research Institute2011
- A Chemical Crosslinking Strategy To Determine DNA Methylating Protein ComplexesNational Cancer Institute2009–2010
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: